During the past decade, Hematology & Oncology Associates of Virginia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology & Oncology Associates of Virginia" #1 collaborator was "Smith Kline Beecham" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hematology & Oncology Associates of Virginia" are "Lung Cancer" (2 trials), "Colorectal Cancer" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Hematology & Oncology Associates of Virginia" in a lesser frequency.

Most popular intervention types in "Hematology & Oncology Associates of Virginia" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "filgrastim" (2 trials), "FOLFOX regimen" (1 trials), "cyclophosphamide" (1 trials), "docetaxel" (1 trials) and "doxorubicin hydrochloride" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hematology & Oncology Associates of Virginia" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hematology & Oncology Associates of Virginia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hematology & Oncology Associates of Virginia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hematology & Oncology Associates of Virginia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".